By NEXS Technology Group NEXS Technology Group is excited to announce its acceptance into the prestigious AWS Startup Program, a significant milestone that will propel the development and deployment of CancerScope-AI, our state-of-the-art artificial intelligence tool.
|
By NEXS BioMedica Corporation NEXS BioMedica, a forward-thinking biotech pharmaceutical company, proudly introduces CancerScope-AI, an innovative artificial intelligence system set to transform the battle against rare cancers.
|
By Manhattan BioSolutions, Inc. Manhattan BioSolutions, Inc. ("MABS"), an emerging biotechnology company developing new classes of precision biologics that harness natural host defense mechanisms, today announced that its RNA-targeting therapeutic, MABS-139, will be evaluated in...
|
By Maxis Clinical Sciences New Global Centre to Advance Clinical Research and Digital Innovation
|
By Manhattan BioSolutions, Inc. Manhattan BioSolutions, Inc. (Manhattan Bio or MABS), an emerging biotech company developing innovative precision biologics, today announced its selection as an awardee of the Science in the City QuickFire Challenge launched by Johnson & Johnson...
|
By Hoth Intelligence Hoth Intelligence, a health care augmented reality software company, announced today that the U.S.
|
By Trishul Biotech Trishul Biotech is a pioneering provider of agricultural biotechnology solutions, specializing in bio fertilizers, organic fertilizers, bio insecticides, and bio pesticides.
|
By Creative Biolabs Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
|
 | By Successful Human Factors™ SHF 2.0 Framework as Practical Solution to Drive Continuous Improvement
|
By Temple Therapeutics Rope-like bands of internal scar tissue that form in 70-90% of patients who undergo abdominal surgery have bedeviled patients and surgeons since medical literature history's recording of adhesions in 1836
|
